Skip to main content
OpenTrials
Completed

NCT Number: NCT05828836

Allopurinol and Quality of Life in Liver Cirrhosis

The study aims to evaluate the impact of allopurinol on patients' related quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cirrhosis, Liver Digestive System Diseases Fibrosis Liver Cirrhosis Liver Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Faculty of Pharmacy

Tanta, 31679, Egypt

About this study

Cirrhosis is the late stage of liver damage and possess two phases:. The shift from compensated to decompensated cirrhosis is characterized by the onset of complications) which are associated with substantial morbidity and negative Impact on quality of life (QOL)Cirrhosis and its complications have a substantial economic, social, and personal impact on affected patients, as well as their families and caregivers

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

cirrhosis adult both sex

Exclusion criteria

  • renal insufficiency

Treatment and study plan

Allopurinol Tablet

Drug

allopurinol300mg once daily

Placebo

Drug

placebo once daily

Primary outcomes

  1. Chronic liver disease questionnaire

    Time frame: 6 months

    effect on Chronic liver disease questionnaire score

Sponsors and collaborators

Lead sponsor

Tanta University

Other

Registry information

Official study title

the Impact of Allopurinol of HRQOL in Cirrhotic Patients

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Apr 25, 2023
Registry last updated
Oct 31, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.